340B Resource Center
340B Program Strategy
-
Capture Rate Benchmarks: What “Good” Actually Looks Like in 2026
Read Resource →: Capture Rate Benchmarks: What “Good” Actually Looks Like in 2026Every 340B covered entity eventually asks the same question: What should our capture rate be? The honest answer is that there is no single industry number.…
-
Is 340B Still Worth It in 2027? A CFO’s Framework for Measuring the Program’s True Value
Read Resource →: Is 340B Still Worth It in 2027? A CFO’s Framework for Measuring the Program’s True ValueFor CFOs and executive leaders at FQHCs and other 340B covered entities, “Is 340B still worth it?” is no longer a pharmacy department question. It is…
-
From Contract Pharmacy to In-House: A 12-Month FQHC Conversion Playbook
Read Resource →: From Contract Pharmacy to In-House: A 12-Month FQHC Conversion PlaybookFor many Federally Qualified Health Centers, the contract pharmacy model no longer provides the predictability it once did. Manufacturer restrictions, product-specific exclusion lists, claims-data requirements, and…
-
340B Telehealth and Patient Eligibility: What FQHCs Must Document When the Visit Is Virtual
Read Resource →: 340B Telehealth and Patient Eligibility: What FQHCs Must Document When the Visit Is VirtualFor Federally Qualified Health Centers (FQHCs), telehealth can expand access to primary care, behavioral health, and other in-scope services. It can also create a documentation nightmare…
-
Medicaid Carve-Out vs. Carve-In: Choosing the Right 340B Billing Model for Your FQHC
Read Resource →: Medicaid Carve-Out vs. Carve-In: Choosing the Right 340B Billing Model for Your FQHCFor an FQHC, choosing between Medicaid 340B carve-in and carve-out is not a routine billing preference. It is a compliance, cash-flow, and operating-model decision. Under Section…
-
2027 340B Outlook: 5 Predictions Every Covered Entity Should Plan Around
Read Resource →: 2027 340B Outlook: 5 Predictions Every Covered Entity Should Plan AroundFor FQHCs and other 340B covered entities, 2027 is unlikely to be a year of business as usual. The program is moving toward more claims-level data,…
-
8 Best Practices for 340B Claims Management: Capture Every Eligible Saving and Stay Audit-Ready
Read Resource →: 8 Best Practices for 340B Claims Management: Capture Every Eligible Saving and Stay Audit-ReadyUnder Section 340B of the Public Health Service Act, the 340B Drug Pricing Program helps eligible covered entities stretch limited resources to support patient care. For…
-
Beyond the Bottom Line: How Covered Entities Use 340B Savings to Serve Their Communities
Read Resource →: Beyond the Bottom Line: How Covered Entities Use 340B Savings to Serve Their Communities340B savings can help covered entities expand access, reduce medication barriers, strengthen staffing, and invest in the services their communities need. Learn how to document and…
-
How to Protect Your FQHC Cash Flow From the Proposed CMS 340B Payment Cuts
Read Resource →: How to Protect Your FQHC Cash Flow From the Proposed CMS 340B Payment CutsAs an FQHC Chief Financial Officer or executive leader, your inbox is likely flooded with alerts regarding federal reimbursement changes. With recent policy discussions surrounding CMS…
-
7 Mistakes You’re Making with OPAIS and MEF Maintenance (And How to Avoid an Audit Finding)
Read Resource →: 7 Mistakes You’re Making with OPAIS and MEF Maintenance (And How to Avoid an Audit Finding)Review common OPAIS and Medicaid Exclusion File maintenance mistakes that can create audit exposure, and learn practical steps to strengthen registration accuracy, documentation, and ongoing 340B…
Need Help Applying This to Your 340B Program?
GapRx can help translate 340B requirements, operational changes, manufacturer policies, pharmacy performance data, and compliance priorities into practical next steps for your organization.